Moderate coffee drinking has been linked to lower rates of heart disease, stroke and type two diabetes.
Research released this week in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism found people who drank around three cups of coffee a day had a lower prevalence of cardiometabolic diseases.
The finding were based on data from the UK Biobank, a longitudinal dietary study involving more than 500,000 people aged from 37 to 73 years.
Study lead author Chaofu Ke said coffee and caffeine consumption could play an important protective role in almost all phases of cardiometabolic development.
“Consuming three cups of coffee, or 200-300 mg caffeine, per day might help to reduce the risk of developing cardiometabolic multimorbidity (CM) in individuals without any cardiometabolic disease,” he said.
“The findings highlight that promoting moderate amounts of coffee or caffeine intake as a dietary habit to healthy people might have far-reaching benefits for the prevention of CM.”
The study found that, compared with non-consumers or consumers of less than 100mg caffeine per day, consumers of moderate amount of coffee (three drinks per day) or caffeine (200-300 mg per day) had a 48.1 percent or 40.7 percent reduced risk for new-onset cardiometabolic disease (CM).
“Coffee and caffeine intake at all levels were inversely associated with the risk of new-onset CM in participants without cardiometabolic diseases,” the research report said.
The full study is called “Habitual Coffee, Tea and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity“.
The Endocrine Society is the world’s oldest and largest organisation of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
